Chemical formula: C₁₇H₁₈N₂O₅S Molecular mass: 362.4 g/mol PubChem compound: 4849
Piretanide must not be used during the first trimester of pregnancy. There is insufficient experience to assess the safety of its use in the later phases of pregnancy.
Piretanide must not be administered to breast-feeding women because the active substance piretanide is excreted in breast milk. If necessary, weaning should take place.
Treatment with piretanide requires regular medical checks. In individual cases reduced mental alertness may impair the ability to drive or operate dangerous machinery. This is most likely at the beginning of treatment, when there is a dose increase or a change of drug and in interaction with alcohol.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
